Found 20 results
Name | Type of Offering | Accepted Date |
---|---|---|
Phylos Bioscience, Inc.
See All Filings
|
D/A | 2021-04-19 14:51:12 |
Amount To Be Raised
$26,000,000
Associated Brokers / Dealers
N/A
CIK Number
0001630986
Filed Document
0001630986-21-000002
Exclusions or Exemptions
506c
Accepted Date
2021-04-19 14:51:12
Type of Offering
D/A
Industry
Other
Offering Tier
N/A
Principal Place of Business
OREGON
Revenue or Assets
Decline to Disclose
Type of Security
Equity
|
||
Phylos Bioscience, Inc.
See All Filings
|
D | 2023-11-07 11:51:11 |
Amount To Be Raised
Indefinite
Associated Brokers / Dealers
N/A
CIK Number
0001630986
Filed Document
0001630986-23-000003
Exclusions or Exemptions
506b
Accepted Date
2023-11-07 11:51:11
Type of Offering
D
Industry
Other
Offering Tier
N/A
Principal Place of Business
OREGON
Revenue or Assets
Decline to Disclose
Type of Security
Equity
|
||
Phylos Bioscience, Inc.
See All Filings
|
D | 2021-05-04 18:20:03 |
Amount To Be Raised
$5,000,000
Associated Brokers / Dealers
N/A
CIK Number
0001630986
Filed Document
0001630986-21-000003
Exclusions or Exemptions
506b
Accepted Date
2021-05-04 18:20:03
Type of Offering
D
Industry
Other
Offering Tier
N/A
Principal Place of Business
OREGON
Revenue or Assets
Decline to Disclose
Type of Security
Equity
|
||
Phylos Bioscience, Inc.
See All Filings
|
D/A | 2022-01-24 13:44:58 |
Amount To Be Raised
Indefinite
Associated Brokers / Dealers
N/A
CIK Number
0001630986
Filed Document
0001630986-22-000001
Exclusions or Exemptions
506b
Accepted Date
2022-01-24 13:44:58
Type of Offering
D/A
Industry
Other
Offering Tier
N/A
Principal Place of Business
OREGON
Revenue or Assets
Decline to Disclose
Type of Security
Equity
|
||
Phylos Bioscience, Inc.
See All Filings
|
D | 2021-12-10 15:51:39 |
Amount To Be Raised
Indefinite
Associated Brokers / Dealers
N/A
CIK Number
0001630986
Filed Document
0001630986-21-000004
Exclusions or Exemptions
506b
Accepted Date
2021-12-10 15:51:39
Type of Offering
D
Industry
Other
Offering Tier
N/A
Principal Place of Business
OREGON
Revenue or Assets
Decline to Disclose
Type of Security
Equity
|
||
Phylos Bioscience, Inc.
See All Filings
|
D | 2019-01-03 14:33:24 |
Amount To Be Raised
$20,000,000
Associated Brokers / Dealers
N/A
CIK Number
0001630986
Filed Document
0001630986-19-000001
Exclusions or Exemptions
506b
Accepted Date
2019-01-03 14:33:24
Type of Offering
D
Industry
Other
Offering Tier
N/A
Principal Place of Business
OREGON
Revenue or Assets
Decline to Disclose
Type of Security
Equity
|
||
Phylos Bioscience, Inc.
See All Filings
|
D | 2020-01-29 18:28:37 |
Amount To Be Raised
$25,000,000
Associated Brokers / Dealers
N/A
CIK Number
0001630986
Filed Document
0001630986-20-000001
Exclusions or Exemptions
506b
Accepted Date
2020-01-29 18:28:37
Type of Offering
D
Industry
Other
Offering Tier
N/A
Principal Place of Business
OREGON
Revenue or Assets
Decline to Disclose
Type of Security
Equity
|
||
Phylos Bioscience, Inc.
See All Filings
|
D/A | 2025-01-23 11:40:02 |
Amount To Be Raised
Indefinite
Associated Brokers / Dealers
N/A
CIK Number
0001630986
Filed Document
0001630986-25-000001
Exclusions or Exemptions
506b
Accepted Date
2025-01-23 11:40:02
Type of Offering
D/A
Industry
Other
Offering Tier
N/A
Principal Place of Business
OREGON
Revenue or Assets
Decline to Disclose
Type of Security
Equity
|
||
Phylos Biosciences LLC
See All Filings
|
D | 2015-02-02 |
Amount To Be Raised
$2,000,000
Associated Brokers / Dealers
N/A
CIK Number
0001630986
Filed Document
0001630986-15-000001
Exclusions or Exemptions
506b
Accepted Date
2015-02-02
Type of Offering
D
Industry
Other
Offering Tier
N/A
Principal Place of Business
OREGON
Revenue or Assets
No Revenues
Type of Security
Equity
|
||
Phylos Biosciences LLC
See All Filings
|
D/A | 2015-09-18 |
Amount To Be Raised
$3,000,000
Associated Brokers / Dealers
N/A
CIK Number
0001630986
Filed Document
0000892917-15-000027
Exclusions or Exemptions
506b
Accepted Date
2015-09-18
Type of Offering
D/A
Industry
Other
Offering Tier
N/A
Principal Place of Business
OREGON
Revenue or Assets
Decline to Disclose
Type of Security
Equity
|
||
Phylos Bioscience, Inc.
See All Filings
|
D/A | 2021-01-27 12:06:26 |
Amount To Be Raised
$25,000,000
Associated Brokers / Dealers
N/A
CIK Number
0001630986
Filed Document
0001630986-21-000001
Exclusions or Exemptions
506b
Accepted Date
2021-01-27 12:06:26
Type of Offering
D/A
Industry
Other
Offering Tier
N/A
Principal Place of Business
OREGON
Revenue or Assets
Decline to Disclose
Type of Security
Equity
|
||
Phylos Bioscience, Inc.
See All Filings
|
D | 2023-02-17 09:28:26 |
Amount To Be Raised
$1,000,000
Associated Brokers / Dealers
N/A
CIK Number
0001630986
Filed Document
0001630986-23-000002
Exclusions or Exemptions
506b
Accepted Date
2023-02-17 09:28:26
Type of Offering
D
Industry
Other
Offering Tier
N/A
Principal Place of Business
OREGON
Revenue or Assets
Decline to Disclose
Type of Security
Equity
|
||
Phylos Bioscience, Inc.
See All Filings
|
D/A | 2024-01-23 19:22:52 |
Amount To Be Raised
Indefinite
Associated Brokers / Dealers
N/A
CIK Number
0001630986
Filed Document
0001630986-24-000001
Exclusions or Exemptions
506b
Accepted Date
2024-01-23 19:22:52
Type of Offering
D/A
Industry
Other
Offering Tier
N/A
Principal Place of Business
OREGON
Revenue or Assets
Decline to Disclose
Type of Security
Equity
|
||
Phylos Biosciences LLC
See All Filings
|
D | 2015-09-16 |
Amount To Be Raised
$1,000,000
Associated Brokers / Dealers
N/A
CIK Number
0001630986
Filed Document
0000892917-15-000026
Exclusions or Exemptions
506b
Accepted Date
2015-09-16
Type of Offering
D
Industry
Other
Offering Tier
N/A
Principal Place of Business
OREGON
Revenue or Assets
Decline to Disclose
Type of Security
Equity
|
||
Phylos Bioscience, Inc.
See All Filings
|
D/A | 2016-09-16 14:30:28 |
Amount To Be Raised
$5,500,000
Associated Brokers / Dealers
N/A
CIK Number
0001630986
Filed Document
0001630986-16-000003
Exclusions or Exemptions
506b
Accepted Date
2016-09-16 14:30:28
Type of Offering
D/A
Industry
Other
Offering Tier
N/A
Principal Place of Business
OREGON
Revenue or Assets
Decline to Disclose
Type of Security
Equity
|
||
Phylos Bioscience, Inc.
See All Filings
|
D | 2017-12-26 08:38:12 |
Amount To Be Raised
$10,000,000
Associated Brokers / Dealers
N/A
CIK Number
0001630986
Filed Document
0001630986-17-000001
Exclusions or Exemptions
506b
Accepted Date
2017-12-26 08:38:12
Type of Offering
D
Industry
Other
Offering Tier
N/A
Principal Place of Business
OREGON
Revenue or Assets
Decline to Disclose
Type of Security
Equity
|
||
Phylos Bioscience, Inc.
See All Filings
|
D/A | 2020-05-05 11:29:56 |
Amount To Be Raised
$26,000,000
Associated Brokers / Dealers
N/A
CIK Number
0001630986
Filed Document
0001630986-20-000002
Exclusions or Exemptions
506c
Accepted Date
2020-05-05 11:29:56
Type of Offering
D/A
Industry
Other
Offering Tier
N/A
Principal Place of Business
OREGON
Revenue or Assets
Decline to Disclose
Type of Security
Equity
|
||
Phylos Bioscience, Inc.
See All Filings
|
D/A | 2023-01-26 13:33:15 |
Amount To Be Raised
Indefinite
Associated Brokers / Dealers
N/A
CIK Number
0001630986
Filed Document
0001630986-23-000001
Exclusions or Exemptions
506b
Accepted Date
2023-01-26 13:33:15
Type of Offering
D/A
Industry
Other
Offering Tier
N/A
Principal Place of Business
OREGON
Revenue or Assets
Decline to Disclose
Type of Security
Equity
|
||
Phylos Bioscience, Inc.
See All Filings
|
D/A | 2019-05-10 12:58:18 |
Amount To Be Raised
$26,000,000
Associated Brokers / Dealers
N/A
CIK Number
0001630986
Filed Document
0001630986-19-000002
Exclusions or Exemptions
506c
Accepted Date
2019-05-10 12:58:18
Type of Offering
D/A
Industry
Other
Offering Tier
N/A
Principal Place of Business
OREGON
Revenue or Assets
Decline to Disclose
Type of Security
Equity
|
||
Phylos Bioscience, Inc.
See All Filings
|
D | 2024-11-01 17:28:42 |
Amount To Be Raised
$4,000,000
Associated Brokers / Dealers
N/A
CIK Number
0001630986
Filed Document
0001630986-24-000002
Exclusions or Exemptions
506b
Accepted Date
2024-11-01 17:28:42
Type of Offering
D
Industry
Other
Offering Tier
N/A
Principal Place of Business
OREGON
Revenue or Assets
Decline to Disclose
Type of Security
Equity
|